tradingkey.logo
tradingkey.logo
Search

LeMaitre Vascular Inc

LMAT
Add to Watchlist
98.740USD
+2.780+2.90%
Close 07/01, 16:00ETQuotes delayed by 15 min
2.25BMarket Cap
35.90P/E TTM

More Details of LeMaitre Vascular Inc Company

LeMaitre Vascular, Inc. is a provider of devices, implants, and services for the treatment of peripheral vascular disease. The Company develops, manufactures, and markets vascular devices to address the needs of vascular surgeons and other specialties, such as cardiac surgeons, general surgeons, and neurosurgeons. Its portfolio of product lines is used to treat vascular disease, which used in open vascular surgery and dialysis access. It also offers human vascular and cardiac tissue cryopreservation services. Its principal product lines include anastomotic clips, biologic vascular and dialysis grafts, biologic vascular and cardiac patches, carotid shunts, embolectomy and occlusion catheters, radiopaque marking tape, synthetic vascular and dialysis grafts, and valvulotomes. Its principal biologic offerings include vascular and cardiac patches as well as vascular and dialysis grafts. Its product offerings are sold primarily in the United States, Europe, Canada, and Asia Pacific.

LeMaitre Vascular Inc Info

Ticker SymbolLMAT
Company nameLeMaitre Vascular Inc
IPO dateOct 19, 2006
CEOLemaitre (George W)
Number of employees651
Security typeOrdinary Share
Fiscal year-endOct 19
Address63 2nd Ave
CityBURLINGTON
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code01803
Phone17812212266
Websitehttps://www.lemaitre.com/
Ticker SymbolLMAT
IPO dateOct 19, 2006
CEOLemaitre (George W)

Company Executives of LeMaitre Vascular Inc

Name
Name/Position
Position
Shareholding
Change
Mr. David Brian (Dave) Roberts
Mr. David Brian (Dave) Roberts
President, Director
President, Director
6.68K
-108.68%
Mr. Lawrence J. (Larry) Jasinski
Mr. Lawrence J. (Larry) Jasinski
Independent Director
Independent Director
3.19K
-33.98%
Mr. Trent G. Kamke
Mr. Trent G. Kamke
Senior Vice President - Operations
Senior Vice President - Operations
2.24K
-198.61%
Ms. Martha Shadan
Ms. Martha Shadan
Independent Director
Independent Director
1.44K
-105.55%
Mr. George W. Lemaitre
Mr. George W. Lemaitre
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
--
--
Mr. Joseph P. Pellegrino, Jr.
Mr. Joseph P. Pellegrino, Jr.
Director
Director
--
--
Mr. John J. O'Connor
Mr. John J. O'Connor
Independent Director
Independent Director
--
--
Ms. Kimberly L. Cieslak
Ms. Kimberly L. Cieslak
Vice President - Marketing
Vice President - Marketing
--
--
Mr. Ryan H. Connelly
Mr. Ryan H. Connelly
Senior Vice President - Advanced Manufacturing Engineering
Senior Vice President - Advanced Manufacturing Engineering
--
--
Mr. Maik D. Helmers
Mr. Maik D. Helmers
Senior Vice President - Sales, Central Europe
Senior Vice President - Sales, Central Europe
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. David Brian (Dave) Roberts
Mr. David Brian (Dave) Roberts
President, Director
President, Director
6.68K
-108.68%
Mr. Lawrence J. (Larry) Jasinski
Mr. Lawrence J. (Larry) Jasinski
Independent Director
Independent Director
3.19K
-33.98%
Mr. Trent G. Kamke
Mr. Trent G. Kamke
Senior Vice President - Operations
Senior Vice President - Operations
2.24K
-198.61%
Ms. Martha Shadan
Ms. Martha Shadan
Independent Director
Independent Director
1.44K
-105.55%
Mr. George W. Lemaitre
Mr. George W. Lemaitre
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
--
--
Mr. Joseph P. Pellegrino, Jr.
Mr. Joseph P. Pellegrino, Jr.
Director
Director
--
--

FAQs

Who are the top five shareholders of LeMaitre Vascular Inc?

The top five shareholders of LeMaitre Vascular Inc are: Mr. David Brian (Dave) Roberts

How many institutions hold shares of LeMaitre Vascular Inc (LMAT)?

As of 2026Q1, 614 institutions hold shares of LeMaitre Vascular Inc, with a combined market value of approximately 23.53M, accounting for 102.98% of the total shares. Compared to 2025Q4, institutional shareholding has increased by 853773.00.